Syncope, a transient loss of consciousness (T-LOC) due to cerebral hypoperfusion, presents a diagnostic challenge for healthcare professionals. Despite its high prevalence, the etiological diagnosis remains elusive in approximately 40% of cases. This article aims to provide a comprehensive approach to better understand and manage syncope.
Syncope can be broadly classified into three categories: reflex (neurally mediated), orthostatic hypotension, and cardiac syncope. Reflex syncope includes vasovagal, situational, and carotid sinus syncope. Orthostatic hypotension is associated with autonomic failure, medications, and volume depletion. Cardiac syncope may be due to arrhythmias or structural heart diseases.
A detailed history and physical examination are crucial in the evaluation of syncope. The history should focus on the prodromal symptoms, triggers, and post-event period. Physical examination should include orthostatic blood pressure measurements and cardiac evaluation. In selected cases, further diagnostic tests such as electrocardiogram, echocardiography, tilt table testing, and loop recorder implantation may be warranted.
Management primarily involves treating the underlying cause. In reflex syncope, patient education, reassurance, and lifestyle modifications are often sufficient. Pharmacological treatment may be considered in recurrent cases. Patients with orthostatic hypotension may benefit from volume expansion, compression stockings, and medications. Cardiac syncope requires prompt referral to a cardiologist for further evaluation and treatment.
Understanding the complex pathophysiology of syncope is key to its effective management. A systematic approach, starting from a thorough history and physical examination to appropriate diagnostic testing and management, can help demystify this common yet often perplexing clinical entity. By adopting this comprehensive approach, healthcare professionals can ensure optimal care for patients presenting with syncope.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation